VYNE Therapeutics (NASDAQ:VYNE) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of VYNE Therapeutics (NASDAQ:VYNE – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning. Separately, HC Wainwright lowered their price target on shares of VYNE Therapeutics from $5.75 to $4.50 and set a “buy” rating on the stock in […]
Wall Street Zen upgraded shares of VYNE Therapeutics (NASDAQ:VYNE – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning. Separately, HC Wainwright lowered their price target on shares of VYNE Therapeutics from $5.75 to $4.50 and set a “buy” rating on the stock in […]
